MARKET

MIRA

MIRA

Mira Pharma
NASDAQ
1.180
-0.040
-3.28%
Closed 19:31 05/13 EDT
OPEN
1.240
PREV CLOSE
1.220
HIGH
1.250
LOW
1.170
VOLUME
247.19K
TURNOVER
--
52 WEEK HIGH
5.01
52 WEEK LOW
0.5100
MARKET CAP
19.84M
P/E (TTM)
-2.3206
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MIRA last week (0505-0509)?
Weekly Report · 1d ago
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
TipRanks · 5d ago
MIRA Pharmaceuticals board approves SKNY Pharmaceuticals acquisition; combined value tops $60M
Seeking Alpha · 5d ago
Mira Pharmaceuticals announces board approval of SKNY acquisition
TipRanks · 5d ago
MIRA Pharmaceuticals Acquires SKNY Pharmaceuticals for $60M
TipRanks · 5d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 5d ago
MIRA PHARMACEUTICALS INC -UNDER DEAL SKNY TO CONTRIBUTE $5 MILLION TO MIRA AT CLOSING - SEC FILING
Reuters · 5d ago
MIRA PHARMACEUTICALS INC - COMBINED ENTERPRISE VALUE EXCEEDS $60 MILLION - SEC FILING
Reuters · 5d ago
More
About MIRA
More
MIRA Pharmaceuticals, Inc. is a clinical-stage pharmaceutical development company. The Company has two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. It holds exclusive license rights in the United States, Canada and Mexico for Ketamir-2 and MIRA-55, two novel drug candidates designed to address unmet medical needs in pain management, depression, PTSD and cognitive function. Ketamir-2 is a patent-pending oral ketamine analog evaluated for the treatment of diabetic neuropathy and is in an ongoing Phase I clinical trial. It is for patients suffering from neuropathic pain, treatment-resistant depression (TRD), major depressive disorder with suicidal ideation (MDD-SI), and post-traumatic stress disorder (PTSD). MIRA-55 is a preclinical-stage investigational drug designed to support cognitive function and enhance memory. It is for the treatment of patients experiencing cognitive decline, including those with early neurodegenerative conditions.
Recently
Symbol
Price
%Change

Webull offers Mira Pharmaceuticals Inc stock information, including NASDAQ: MIRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRA stock methods without spending real money on the virtual paper trading platform.